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INTRODUCTION
Polycyclic aromatic hydrocarbons (PAHs) are widespread
environmental pollutants. The number of publications every
year (Kurihara et al. 2005; Ledesma et al. 2000; Meyer et al.
2005; Oleszczuk and Baran 2005; Russo et al. 2005; Scicchitano
2005; Wolska et al. 2005) may facilitate the understanding of
how many disciplines and subjects may be connected with
PAHs.
One of the most important applications of PAHs is their
use in research on formation of cancer cells (Harvey 1991). In
many cases mutagenic and carcinogenic activity of PAHs has
been confirmed, and the occurrence of many of them is 
determined in routine environmental studies. Their level is
determined in soil, drinking water, river, lake and marine 
sediments, and also in air analysis (Harvey 1997). As mussels
are able to accumulate PAHs in their tissues, some mollusc
species were used in persistent monitoring of the quality of
water (Gewurtz et al. 2002).
Papers on anthropogenic sources of PAHs formation are
well documented in literature, for example on medical waste
plant (Lee et al. 2003) or combustion of coal tar (Ledesma et
al. 2000). PAHs may also arise from non-anthropogenic sources,
such as in soil as a result of degradation of organic matter
(Pope et al. 2000; Thiele and Brummer 2002). A rising number
of compounds classified as mutagens or carcinogens, along
with restrictions in their emission, are subjected to attempts
of the deactivation of PAHs existing in the environment.
Among others, methods involving living organisms, such as
some bacteria strains capable of neutralizing specific hydro-
carbons, have become popular (Caldini et al. 1995). However,
biological activity of these compounds is not restricted to
ABBREVIATIONS 
B[c]P benzo[c]phenanthrene
CP[a]P cyclopenta[a]phenanthrene
CP[c]P cyclopenta[c]phenanthrene
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Hep2G human hepatoma cell line
THB[c]P tetrahydrobenzo[c]phenanthrene
THCH tetrahydrochrysene
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carcinogenicity; some of them are investigated for their anti-
-carcinogenic properties (Banik and Becker 2001; Becker
and Banik 1998). Derivatives of tetrahydrochrysene are 
considered in research on selective estrogen receptors (Tedesco
et al. 2001).
In this paper we present the actual state of knowledge
concerning the correlation between the structure of cyclo-
penta[a]phenanthrene (1), cyclopenta[c]phenanthrene (4),
chrysene (2) and benzo[c]phenanthrene (3) derivatives and
their mutagenic and carcinogenic properties. The oxidative
metabolism of these compounds is described with special 
attention to the paths leading to the most active products. The
nomenclature and numbering of the carbon skeleton of poly-
cyclic compounds follows the IUPAC rules (Nomenclature of
Organic Chemistry 1979) as well as recommended exception
from general rules, used in naming and numbering CP[a]P 
derivatives, which is based on steroid nomenclature (Scheme 1).
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Explanation of terms linked to PAHs structure (such as bay-
-region, fjord-region, pseudo bay-region, pseudo fjord-region
and K-region [Scheme 2]) seems useful for discussion on the
structure-activity correlation of these compounds. Bay-region
consists of three aromatic rings, connected in an angular
manner, creating a recess which resembles a bay; a pseudo bay-
-region is composed of two aromatic rings and terminal aliphatic
ring. Analogically, a fjord region consists of four aromatic rings.
In case of pseudo fjord-region the terminal ring is saturated. All
the mentioned structural elements have a specific impact on
mutagenic and carcinogenic activity of PAH derivatives. As will
be explained in the following sections, changes made in these
fragments of molecule allow for studying the mechanisms of
mutations and, in consequence, of cancer cells formation.
Scheme 2
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METHODS FOR DETERMINING MUTAGENIC AND
CARCINOGENIC PROPERTIES OF PAH DERIVATIVES
Some experiments on the PAHs genotoxic properties can be
performed with the use of human-derived cells, which seems
to be very important from the human medicine point of view.
This subject is revised by Kransmüller and co-workers (2004).
Other methods for estimation of different potentially dange-
rous properties of PAHs will be briefly reviewed; this should
facilitate further understanding of the terms used in the text.
Nuclear abnormalities (NA)
Several types of variations from the usual erythrocyte nuclear
morphology can be observed following exposure to a PAH
contaminant. According to Carrasco et al. (1990), the nuclear
abnormalities can be classified into five categories. Micronuclei
are non-refractory structures, of the same color as the nucleus
and with a round, almond or ovoid shape about one-fifth the
size of the main nucleus; “blebbed” nuclei present a relatively
small evagination (bleb) of the nuclear envelope which seems to
contain euchromatin; “lobed” nuclei are those with evaginations
larger than blebs described above; “notched” nuclei present an
appreciable depth into a nucleus that does not contain nuclear
material; and “vacuolated” nuclei are those with a well-defined
hole devoid of any visible material. Whereas the model appeared
to be sensitive in screening the mutagenic activity of chemical
compounds under laboratory conditions (Pacheco and Santos
1996), the low and variable frequencies of the nuclear lesions
scored from the field samples may present serious difficulty to
the useful application of the test (e.g. Carrasco et al. 1990).
DNA strand breakage (SB) and comet assay
Sensitive measurements of DNA strand breakage can be
achieved by a variety of methods, e.g. alkaline elution, alkaline
unwinding or by single cell gel (comet) electrophoresis (reviewed
by Mitchelmore and Chipman 1998). Singh and co-workers
(1988) were the first to adapt a number of earlier methods to
develop an assay of single cell gel electrophoresis under alkaline
conditions to emphasize the occurrence of DNA strand breakage.
The subsequent visualization of mobility of DNA fragments
from the nucleus (the “comet” analysis) is a very sensitive
and convenient way to detect strand breakage in individual
cells. A range of genotoxic chemicals (both with and without
the requirement for metabolic activation) gave positive effects in
various cell types of vertebrate and invertebrate aquatic species
(see, for example, Pavlica et al. 2000; Woênicki et al. 2004). 
Cytochrome P450
Polycyclic aromatic hydrocarbons stimulate expression of
various members of the cytochrome P450 family of genes
(CYP), particularly those of the CYP1 family. The induction
of hepatic CYP1A in fish by certain classes of chemicals has
been suggested as an early warning system, a most sensitive
biological response for assessing environmental contamination
conditions (Arin˜ et al. 2000, and references therein). This
has implications for human consumption of fish, as well as for
the health status of aquatic organisms.
The cytochrome P450 detoxification system is, thus, an
extensively studied enzyme system and has been found in
bacteria, plants, and animals. It is involved in the metabolism of
such compounds such as steroids, prostaglandins, eicosanoids,
drugs, and xenobiotics (Nelson et al. 1996). Cytochrome P450,
the terminal oxidase of monooxygenases, is mainly localized in
the endoplasmic reticulum and in mitochondria of vertebrates.
It catalyzes oxidation of a number of organic chemicals to
more soluble metabolites, which can be further conjugated by
Phase II enzymes and then excreted. Cytochrome P450 genes
are highly diverse, approximately 120 different subfamilies
of cytochrome P450 (CYP) genes have been identified and
characterized by a wide range of xenobiotic-metabolizing
functions. The most intensively studied cytochrome P450
protein is cytochrome P4501A, CYP1A (Stegeman et al. 2001).
Two genes (CYP1A1 and CYP1A2) in mammals characterize
well the CYP1A family. Both genes are coordinately regulated by
the same aromatic hydrocarbon receptor (AhR) (see review by
Hahn et al. 2005). It is known that CYP1A metabolizes several
PAHs to reactive electrophilic metabolites that form DNA
adducts and induce oxidative DNA damage. Thus, the increased
synthesis of CYP1A may ultimately result in carcinogenicity
(Burczynski and Pennig 2000). In fish, CYP1A seems to exist as
a hybrid protein coded by a gene ancestral to both mammalian
CYP1A1 and CYP1A2 forms, and the use of the name CYP1A
rather than CYP1A1 has been suggested (Stegeman 1995).
The mechanism of CYP1A induction has been examined
in many teleost fish species, including rainbow trout (Cao et
al. 2000). Its gene (CYP1A) is highly inducible by PAHs, 
polychlorinated biphenyls (PCB’s), furans and dioxins. Early
work demonstrating induction of CYP1A mRNA in fish in
response to PAH used Northern blot analysis (Stegeman 1995).
With advances in molecular biology techniques, determination
of CYP1A mRNA levels by quantitative reverse transcription
polymerase chain reaction (RT-PCR) has been added to bio-
monitoring studies (see for example Cao et al. 2000; Rees et al.
2003). A fairly new technology that emerged in the early 1990s
is quantitative real-time PCR (Q-PCR). The Q-PCR reaction is
monitored in real time by fluorescence either with the incorpo-
ration of the SYBR green dye that fluoresces only when it is
intercalated into DNA or by a fluorescent probe that is com-
plementary in sequence to the cDNA of interest (Higuchi et
al. 1993). Recently Rees and Li (2004) have developed and
evaluated a real-time quantitative PCR assay for measuring the
induction of liver CYP1A mRNA in four salmonid species.
P53 protein
The p53 tumor suppressor is an universal sensor of genotoxic
stress that regulates the transcription of genes required for cell-
-cycle arrest and apoptosis in vertebrates as diverse as fish and
humans (Soussi et al. 1990). Somatic mutations of the p53 gene,
particularly mutations within the DNA sequence-specific binding
domain, are often associated with the loss of tumor suppressor
activity and may also result in the gain of oncogenic function
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(Greenblatt et al. 1994). Damage of this gene was reported in 50%
of a total number of human tumors and in 60% cases of human
lung tumors (Bennett et al. 1999; Greenblatt et al. 1994; Harris
1996). Sequencing of the p53 gene and structural analysis of the
p53 protein from several vertebrate species revealed 11 exons with
five well-conserved functional domains (I-V) that are involved in
DNA-protein interactions and stabilization of protein conforma-
tion (Krause et al. 1997). Analyses of mutational spectra from
tumors in vertebrates have identified numerous mutational ‘hot-
spots’ which are located primarily within conserved domains II-V
and are involved in sequence-specific DNA. A large proportion
of p53 mutations involve G:C→A:T transitions and G:C→T:A
transversions, alterations frequently associated with such muta-
gens as alkylating agents (Crook and Vousden 1992). The fish p53
sequences have been used in mutational studies to fingerprint
genotoxins in the aquatic environment (Bhaskaran et al. 1999).
Ames test
One of the methods for determining mutagenic activity of specific
compound is a bacterial test developed by Ames and co-
-workers (1975). In this simple and quick (48 hours) test specifi-
cally mutated strains of Salmonella typhimurium are used. Mu-
tants are not capable of synthesizing histidine and are unable to
grow colonies on agar without this amino acid. TA 98 and TA 100
are the most popular strains used in research on mutagenic pro-
perties of activated PAHs. After the treatment of bacteria with
promutagene with activating system (S9 fraction containing mi-
crosomal enzymes from rat liver), mutations in some bacterial cells
are observed. In this way revertants are formed because action of
mutagen “reverts” the inability of certain strains to synthesize
histidine, and this, in turn, allows their growth. Counting colonies
on a Petri plate and comparing the results with control plates
(positive with known mutagen versus negative with no mutagen)
mutagenic activity of a given compound can be estimated. There
exist many modifications of the Ames test, as well as many new
bacteria strains designed for this purpose (Traczewska 2002).
Experiments on rodents
Experiments on rodents are the only kind of investigation
that allow for defining a compound as carcinogen. Such expe-
riments are very expensive (several hundred experimental
animals needed) and long-lasting (about 2 years) (Williams et
al. 2000). In experiments on rodents (skin painting test) Iball
index is used for quantitative estimation of carcinogenic activity
of a specific compound (Coombs and Bhatt 1987).
Theoretical predictions
Apart from biological methods that allow for obtaining direct
results on mutagenic or carcinogenic activity, there exist a number of
computer databases and software for theoretical prediction of such
properties. Such methods provide information that justifies further
biological experiments. For example program DEREK [Deductive
Estimation of Risk from Existing Knowledge (after Long and Com-
bes 1995)] is based on the correlation of the structure of the investi-
gated compound with existing knowledge about the effects caused
by similar structures. Structural data combined with data concer-
ning potential metabolizing of similar structures by P450 enzymes
leading to active arrangements (like bay-region diolepoxides) allow
the prediction of potential mutagenic or carcinogenic activity.
METABOLIC ACTIVATION OF POLYCYCLIC 
AROMATIC HYDROCARBONS
Polycyclic aromatic hydrocarbons themselves are not carcino-
genic; their carcinogenic activity is generated on the metabolic
pathway. Concerning the variability of oxidizing systems based
on the family of CYP1 (P450), oxidation of different parts of
a molecule is possible.
In the case of PAHs the correct mechanism of removing
the potential toxin from the organism, leads through oxidation of
K-region of a molecule (Jerina and Daly 1974). Such products are
capable of binding to glucuronic acid or glutathione and in this
form they are removed from the organism with other products of
metabolism. K-region has the highest electron density, which
makes it a place for almost defined and localized double bond.
Usually the metabolism of a small percentage of molecules goes
in a different way, and this can lead to mutagenic derivatives. The
percentage of this inappropriate metabolic pathway of certain
PAHs is a result of the specific structure of hydrocarbon. Inter-
action between the terminal aromatic ring of hydrocarbon with
cytochrome P450 (Shimada et al. 2001) leads to epoxidation of
aryl double bond in, for example, ring A of 11-methyl-CP[a]Ph-
-17-one (5). In the next step epoxide is hydrolyzed, and another
bond is oxidized leading to diolepoxides or tetraols (Scheme 3).
Scheme 3
Iball index = x 100
mean latent period in days
*based on the number of animals alive at the time of the apperance
of the first tumor at that group.
percentage of animals with tumor*
87
65
The way in which most PAHs metabolites interact with nuc-
leosides is shown on Scheme 4. (Bachechi and Polcaro 1999)
Electrodonating groups present in a bay region of a molecule
accelerate hydrolysis of diolepoxides and increase their chance
for covalent binding to DNA, eventually leading to mutation.
Scheme 4
As mentioned above, the metabolic path leading to muta-
gen or carcinogen goes through a state of epoxide, diol and
finally diolepoxide (Scheme 3). However, depending on the
activating medium used, a variety of products is obtained. For
example, activation of ketone 5 with microsomal fraction of
rat liver, mainly follows the way shown on scheme 3 (Abbott
and Coombs 1981; Coombs et al. 1979). Metabolic profile of
compound 5, obtained by influence of Hep2G does not show
the effect of the action of the P450 system that should lead to
epoxidation of ring A of the molecule; instead, one of the
main metabolites is 17-alcohol. This can be explained by the
presence of specific reductase in this line that reacts with
carbonyl function of compound 5. The presence of other
metabolites of ketone 5 is probably an effect of the action of
aromatic hydrocarbon hydroxylase system (AHH) which is also
present in this line. Examples of complexity of metabolism of
16,17-dihydro-11-methylCP[a]P depending on of the type of
cells used in the experiment are described by Bhatt (1986). An
interesting comparison of metabolic profile of benzo[a]pyrene,
chrysene (2) and phenanthrene, activated with microsomal
fraction from rat liver and catfish (Ictalurus nebulosus), has been
described by Pangrekar and coworkers (1995). The main conclu-
sion concerns a significantly lower degree of metabolizing PAHs
by fish microsomes in comparison with the action of rat micro-
somes. Analogical experiments performed with chrysene (2) and
5-methylchrysene using microsomes of rat and rainbow trout
(Oncorhynchus mykiss) showed a very similar degree of transfor-
mation of the studied hydrocarbons (Shappell et al. 2003).
The process of oxidation of aromatic rings is not the only
way to produce hazardous derivatives of PAHs. As described
recently, there exists an alternative way, leading through 
enzymatic oxidation of alicyclic rings of CP[a]P (Catterall et
al. 2000). 11-Methoxy-16,17-dihydro-15H-CP[a]P activated
with microsomal fraction of rat liver (S9) produced a mixture
of metabolites that were separated and identified by their
comparison to the compounds obtained in a synthetic way
(Coombs and Boyd 1998). The Ames test showed that only
the 16,17-dihydro-15-hydroxy-11-methoxy-15H-CP-[a]P proved
to be a mutagen. A way to explain this surprising fact is based
on an analogy to safrole (9), which is a weak hepatocarcinogen,
and in an attempt to find structural correlation between these
two compounds. Inactivation of safrole goes through hydro-
xylation of benzylic position, formation of sulfuric ester and
cleavage of C-O bond. Carbocation (11) obtained in this way
is carcinogenous (Scheme 5).
Scheme 5
According to Coombs and Boyd (1998), “alternative” activa-
tion of the 16,17-dihydro-15-hydroxy-11-methoxy-15H-CP[a]P
could go through analogical transformations.
Metabolism of PAHs substituted with amino group and
metabolites of such compounds have not been investigated so
far. Their activation process is described only theoretically,
and there are two hypotheses: the classical one leading to
diolepoxides and the other, based on direct oxidation of an
amino group, leading to nitrenium ion ArNH+(Ford and
Griffin 1992; Ford and Herman 1992).
CORRELATION BETWEEN STRUCTURE 
AND MUTAGENIC OR CARCINOGENIC ACTIVITY 
OF POLYCYCLIC AROMATIC HYDROCARBONS
Relationships between the structure of PAHs and their muta-
genic or carcinogenic activity may be of dual nature. One is
related to the structure of the aromatic skeleton of the mole-
cule. For instance, unsubstituted benzo[a]pyrene is one of the
most potent procarcinogens examined. However, recent studies
encompass not only the structure of aromatic fragment but,
first of all, the substitution pattern of its skeleton. For example,
3-methylcholantrene exhibits even higher mutagenic properties
than benzo[a]pyrene. Investigations concerning the relationship
between the structure of an arrangement and its biological acti-
vity usually comprise the same aromatic skeleton, but vary in the
location and character of substituents (Coombs and Bhatt 1987).
In structure-activity studies deformation of planarity of
an aromatic molecule is one of the most important issues.
Determination of this effect can be accomplished in two
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ways: one of them is the introduction of a substituent into a bay
region, and another is benzannelation of appropriate parts of
a hydrocarbon. When the bay region is changed into the fjord
region, the planarity of a molecule also becomes deformed.
This change provides easier access to an epoxide ring of
carcinogenic diolepoxide which, in consequence, facilitates
its covalent binding to the DNA. 
In the case of CP[a]P (1), a very significant increase in its
harmful biological properties is observed when a double bond
is introduced into an alicyclic ring, or when a hydrocarbon 
is transformed to ketone by oxidizing the aliphatic part of 
a molecule (Coombs and Bhatt 1987). An analogical relationship
is observed in the case of THCH (Scheme 6). 
Scheme 6
Ketone 12 is the most potent carcinogen, exceeding harmful
properties of compounds 13, 14, and also dimethylchrysene 15
(Hecht et al. 1974).
As mentioned earlier, the bay region of a PAH molecule
constitutes its most important part, and is responsible for its
mutagenic activity. CP[a]P (1) provides a very good example
for this theory – the unsubstituted hydrocarbon does not
exhibit any significant activity while its derivative, substituted
in position 11 with an electrodonating group (e.g. methyl),
becomes a highly potent mutagen. A similar effect is induced
by introduction of methoxyl or hydroxyl group. Recent studies
on the effects of an amino group in position 11 of CP[a]P (1)
agree well with the supposition that an activating group in
a bay region of PAH increases its mutagenic properties (Catterall
et al. 2001). 
Cyclopenta[a]phenanthrene
Monograph by Coombs and Bhatt (1987) brings a detailed
description of the correlation between the substitution pattern
of CP[a]P (1) and mutagenic and carcinogenic properties
of a specific compound. However, this work does not address
all of the possibilities, limiting the scope of substituents 
to methyl and alkoxy groups. The authors conclude that
unsubstituted hydrocarbon (1) as well as its 17-keto derivative
(16) is neither mutagenic nor carcinogenic. Nevertheless,
substitution with an electrodonating group in position 
11 increases their mutagenic and carcinogenic activity
(Scheme 7).
Scheme 7
Detailed research of Baker et al. (1992), who compared
biological activity of 11-methyl-17-ketone 5 and unsubstituted
17-ketone 16, showed that only ketone 5 substituted in position
11 with methyl group exhibits carcinogenic activity. In addition,
the micronuclei test did not show any significant activity 
of ketone 16, while its 11-methyl derivative 5 has strong
carcinogenous activity, comparable to that of benzo[a]pyrene.
It should be noted, that both compounds give a positive 
response in the Ames test (Coombs et al. 1976). A suggested
explanation is that the different structure of metabolites of
both compounds vary in their mutagenic potential. An in vitro
experiment showed, that ketone 5 is metabolized to trans-3R,
4R-dihydrodiol-anti-1,2-epoxide (18), while the metabolite of
unsubstituted ketone 16 is of conformation syn (Hadfield et
al. 1984) (Scheme 8).
Scheme 8
This explains the lack of response in the micronuclei test
as well as in the in vivo experiment on mice, leading to the
conclusion that syn-diolepoxide is not able to form stable DNA
adducts. Another important position in this structure is the
substitution of the C-7 carbon atom with the methyl group.
This substitution may be considered as located in the so called
pseudo bay region of a molecule. Biological activity of such
compounds is significantly higher than that of unsubstituted
ketone 16, but not to such an extent as in the case of the
previously described 11 carbon atom substitutions. Analogical
relationship has been observed in the case of substitution with
methoxy group (Coombs and Bhatt 1987).
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According to the described metabolic pathway that leads to
diolepoxides as a result of oxidation of A ring of CP[a]P (1),
alkyl substituents in this ring should block this kind of activation
and, therefore, prevent the mutagenic activity of a given com-
pound (Coombs and Bhatt 1987). Lack of mutagenic activity of
CP[a]P (1) substituted with the methyl group in position 6 is of
interest because this substitution does not block oxidation of
ring A. This is explained by the specific conformation of the 
by-product 3,4-dihydro-3,4-diol (Boyd et al. 1995a). In arran-
gements that exhibit mutagenic properties this conformation is
described as pseudo-diequatorial. In the case of the discussed
compound 5, the conformation of diol is pseudo-diaxial which
can prevent accommodation or even block the entry of this
metabolite into the active site of cytochrome CYP1A1. This
in turn would block further transformation of diol to the
diolepoxide, that could be capable of interacting with DNA.
Another method leading to the increased mutagenic and
carcinogenic activity of CP[a]P (1) is the introduction of double
bond to the cyclopentane ring or substitution of C-17 carbon
atom with methyl group. Also in this case, substitution in posi-
tions 11 or 7 increases mutagenic activity of a parent compound
(Coombs et al. 1976). Authors (Coombs and Bhatt 1987)
explained low biological activity of the compounds possessing the
abovementioned substituents in other positions. The kind of sub-
stituent in biologically important position (7, 11) also influences
mutagenic and carcinogenic activity of such compounds. Bhatt et
al. (1982) reported results of investigations on the influence of the
length of alkyl chain of ethers, derivatives of CP[a]P-11-ol, on their
mutagenic activity. The authors emphasize the surprising activity
of compounds having a methoxy or hydroxyl group, whereas
the D-ring remained unchanged. In previous works, the authors
suggested that only compound having a double bond, methyl group
or carbonyl function in cyclopentane ring and electrodonating
group in position 11, exhibit moderate to strong mutagenic or
carcinogenic properties. For example, in earlier research (Bhatt
et al. 1982) the authors examined 17-keto-11-ethers noting the
following dependences: 17-keto-11-methoxy-CP[a]P 19a was
a strong initiator of carcionogenic process whereas ethyl ether
19b was less active. Propyl 19c and pentyl 19e ethers did not show
any activity. Surprisingly, 11-butoxy-17-ketone 19d exhibited
moderate mutagenic activity (Boyd et al. 1995b) (Scheme 9).
Scheme 9
The main subject of Bhatt’s work was to examine if there
exists a correlation between evenness of carbon atoms in alkoxy
substituents and carcinogenic activity of a specific compound.
Data for hexyl ether of 17-ketone 19f did not confirm this
hypothesis. Similar results were obtained in the study on the
influence of cyclopenta[a]phenanthrene-17-ketones substituted
with alkoxy group in position 11 on activity of CYP1A1 and
CYP1A2 systems (Boyd et al. 1995b). The strongest effect 
resulting in increased CYP1 and CYP1A2 apoproteins was
observed in the case of ethoxy substituted CP[a]P-17-one 19b,
ketone substituted with methyl group 19a showed a lower 
influence and the elongation of alkyl chain resulted in a lack of
activity in this test. As it was proved the ketone bearing ethoxy
group 19b is unable to bind to the aromatic hydrocarbon 
receptor (Ar), so that the only compound giving positive 
response in the Ames test is 11-methoxy-17-ketone 19a.
Coombs (1999) correlated in an interesting way biological
activity with chemical shift of HC-12 proton in case of 11
substituted CP[a]P. Confirming that the presence of an electro-
donating group in position 11 of CP[a]P will affect increased
mutagenic or carcinogenic activity, he assumed that this will
also increase the electron density of the environment; in that
case the HC-12 proton will be shielded and a signal will be
shifted up to 7.39-7.97 ppm. In the case of biologically inactive
compounds which have electron-accepting substituents in
position 11, signal of HC-12 proton is shifted downfield to
8.38 (for -CN) – 8.43 (for-CF3). As already described, substi-
tution of cyclopenta[a]phenanthrene in position 11 with tri-
fluoromethyl group leads to a loss of its carcinogenic activity
(Boyd et al. 1995c). Substitution with nitrile function should
also lead to such an effect; however such a study has not been
performed yet (Scheme 10).
Scheme 10
Preliminary investigations on the mutagenicity of CP[a]P
substituted with amino function in this position using Salmo-
nella typhimurium TA98 and TA100 strains showed moderate
activity of such compound (Scheme 11). However there is
still a need to study the mutagenic activity of this compound
using strains YG 1023 and YG 1024, which are very sensitive
to mutations caused by amino function.
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Scheme 11
Some of the investigated compounds, for example two
CP[a]P-17-ones 5 and 24 (Scheme 12), exhibit moderate or low
mutagenic activity in the Ames test, while being strong carcino-
gens of high Iball index (Coombs et al. 1976). Compound 24 ex-
hibits much higher mutagenic activity in bacterial assay than com-
pound 5; however 24 has much lower Iball index (17) than 5 (46).
Scheme 12
Another example of a moderate mutagen is 11,12-dimethyl-
-15,16-dihydroCP[a]P-17-one, with an Iball index = 30.
Marrocchi et al. (2001) proposed a different approach in the
modification of CP[a]P in order to study the influence of
changes in CP[a]P skeleton on their mutagenic activity. The
authors investigated the influence of benzannelations and 
introduction of carbonyl function into cyclopentane ring on
mutagenic activity of CP[a]P (1) and CP[c]P. In the case of CP[a]P
skeleton (1), it has been proven that benzannelations of A ring
as well as benzannelations of D ring of this arrangement do not
influence mutagenic properties of these compounds. The pre-
sence of carbonyl function in position 15 as well as in  position 17
increases mutagenic activity of CP[a]P, as does the presence
of a double bond in D ring of a molecule. Benzannelations
decrease biological activity of 15- and 17 ketones; however
they do not suppress it (Marrocchi et al. 2001).
Chrysene
Chrysene (2) is the subject of investigations of numerous 
research groups, working on the theory of chemical carcino-
genesis. Data on mutagenic activity of eleven derivatives of
chrysene using TA100 strain of Salmonella typhimurium has
been presented by Coombs et al. (1976). Similarly to CP[a]P, an
increase of mutagenic and carcinogenic activity of chrysene was
observed while substituting the aromatic skeleton in position
5 (bay region) with a small electrodonating group. Among
monomethyl chrysenes substitution in position 1 causes low
mutagenic activity, but the compound becomes an initiator of
the carcinogenic process. Substitution in positions 2, 3, 4 or 6
results in low carcinogenic activity, well correlated with mutage-
nicity of a specific derivative. Moderate carcinogenic activity
of 5-methylchrysene agrees well with its mutagenic properties.
Data on carcinogenic activity of the above mentioned com-
pounds have been published by Hecht et al. (1974). Unsub-
stituted 1,2,3,4-tetrahydrochrysene-1-one exhibits mutagenic
properties; however it does not show any carcinogenic activity.
Substitution of this skeleton with methyl group in position 11
causes dramatic increase of carcinogenicity (Iball index = 45).
This is comparable with analogical structure, 11-methyl-15,16-
dihydro-CP[a]P-17-one (5), with the carcinogenicity index value
of 46. An interesting case is a series of compounds having 
different saturation stages of ring A of chrysene skeleton. 
Keeping the same substitution pattern with two methyl groups
in positions 1 and 11, it was shown that increasing hydrogenation
of this ring decreases its carcinogenic potency (Scheme 13).
Scheme 13
Among compounds 25 and 26 with Iball indexes of 23 and
10, respectively, no difference in their mutagenic activity was
observed, although this value was much lower for the com-
pound 27. Kimri and Gayoso (1996) attempted theoretical
prediction of carcinogenity of chrysene (2) substituted with
methyl group. As a factor determining chrysene biological 
activity, the authors assumed susceptibility of C1 carbon atom to
electrophilic attack. This process is very similar to the initial
metabolic activation of chrysene (2) in living organisms, i. e.
epoxidation of a double bond of the ring A. In order to simulate
electrophilic attack the protonation of C1 carbon atom was
considered to be a most simple reaction. The obtained data
confirmed the hypothesis connecting carcinogenic activity of
PAHs with existence of bay-region and substitution of bay-
-region with an electrodonating group. Amin and co-workers
(1979) concerned a series of chrysenes substituted with methyl
group in position 5, two methyl groups in positions 5 and 11,
chrysene derivatives bearing groups such as: -CH2OAc, -CH2OH,
-CO2CH3 in position 5 as well as its partially hydrogenated
analogues. Besides 5-methylchrysene and 5,11-dimethyl deri-
vative, none of the above compounds exhibited any particular
mutagenic activity towards Salmonella typhimurium TA100
strain. These data suggest that oxidation of methyl group of
5-methylchrysene is not an important activating step determi-
ning mutagenic properties of 5-methylchrysene metabolites.
The research was inspired by previous data gained by Amin’s
group, who showed that 5-(hydroxymethyl)chrysene, obtained
in in vitro experiments performed with the use of rat liver
homogenate, is one of the main metabolites of 5-methylchrysene.
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In their other work, the authors discuss the influence of the
length of alkyl chain in position 5 of chrysene on its mutagenic
activity (Amin et al. 1988). Diolepoxides, having in the position
5 methyl, ethyl and n-propyl group were synthesized, which
enabled direct estimation of mutagenic activity with no need
for (in vivo or in vitro) enzymatic activation of the parent
compound. The obtained diolepoxides were examined with
the application of the Ames test using S. typhimurium TA100
strain, for which compound 28 with methyl group in position
5 showed highest mutagenic activity (Scheme 14).
Scheme 14
Substitution with ethyl or propyl group in the bay-region
of a molecule as well as substitution with methyl groups in
positions 6 or 11 (compounds 32 and 33) results in a signifi-
cantly lower mutagenic activity of specific diolepoxide. Amin
et al. (1988) hypothesize that the presence of substituent in
position 5 pushes out epoxide ring from the plane of a mole-
cule, making such an arrangement more capable of binding
to the DNA. Therefore enlarging the volume of this substituent
should enhance this effect. Preliminary experiments on the
capability of such arrangements to covalently bind the DNA
of calf thymus showed that its activity decreased with the
increasing length of alkyl substituent. The authors suggest
that methyl derivative of the discussed aromatic skeleton
fulfils exactly the steric conditions required for reaction in
hot spots of mutations in S. typhimurium. Another explanation
could be the inclusion of a mutagen molecule in DNA structure,
which usually precedes covalent binding (Smith et al. 2000).
Deformation of planar structure caused by larger alkyl groups
may be extensive enough to reduce the probability that such
intercalation happens. Results of further in vivo experiments
(Amin et al. 1991) comparing carcinogenic activity of some of
the mentioned compounds agreed well with the data obtained
earlier. The activity of anti-1,2-diol-3,4-epoxides of chrysene
31, 5-methylchrysene 28, 5-ethylchrysene 29 and 5-propyl-
chrysene 30 was established on the basis of experimental
formation of lung tumors in young mice exposed to these
compounds. As expected, diolepoxide 28 derived from 5-methyl-
chrysene showed the highest carcinogenic activity in those
tests. Its activity was 15-30 times stronger than that of other
compounds. Studies on the capability of PAHs to induce lung
tumors based on mutations of p53 suppressor gene, resulting
from the binding of PAHs metabolites to its specific codons,
confirmed the above dependencies (Smith et al. 2000). A detailed
study of diolepoxide derived from 5,6-dimethylchrysene focused
on its carcinogenic activity (Afshar et al. 1999) showed that
introduction of a methyl group in bay-region of a molecule
causes deformation of its planar structure. Deformed geometry
of epoxide ring and planar structure of aromatic rings system
facilitates binding of this metabolite to DNA and, in consequence,
causes mutations leading to the formation of cancer cells.
Studies on metabolites of 3-hydroxychrysene provide an
example of the influence of hydroxyl substituent on the bio-
logical activity of chrysene. One such metabolite, found during
experiments with microsomal fraction of rat liver, was trans-
-1,2-dihydro-1,2,9-trihydroxychrysene (Hodgson et al. 1985). This
triol, when treated with m-chloroperbenzoic acid, forms products
which are capable of covalent binding to DNA in vitro (Phillips
et al. 1986). Anti-triolepoxide showed the highest capability
of interacting with DNA, which was 1.7 times stronger than that
of anti-diolepoxide. About 10 times less activity was estimated
for isomers syn, while derivatives having epoxide ring in K-region
were even less reactive than syn isomers. As it was shown, the
presence of hydroxyl group in position 3 of chrysene signi-
ficantly increases its harmful biological activity.
Another substitution in chrysene skeleton is amino function.
For instance, Catterall et al. (2001) describe a series of com-
parative Ames tests on specific S. typhimurium strains, perfor-
med for 2-aminochrysene and 5-aminochrysene. The latter
exhibited much lower mutagenic activity than 2-aminochrysene.
The authors conclude that the amino substituted PAHs undergo
a different metabolic path. The theory of direct oxidation of
amino group leading to nitrenium ion is discussed by Ford
and Herman (1992). In case of this way of activation, the
structure of aromatic skeleton of a molecule is extremely im-
portant. According to theoretical calculations and due to the
fact that 5-aminochrysene amino group is connected to carbon
atom, which in turn is directly connected to a tertiary carbon
atom of the aromatic skeleton of molecule (Ford and Griffin,
1992), nitrenium ion which is generated in case of 5-amino-
chrysene, will be less stable than that from 2-aminochrysene.
Cyclopenta[c]phenanthrene
At present there is a lack of model compounds enabling sys-
tematic investigations into biological activity of CP[c]P(4),
which remains relatively unknown among well examined PAHs
with a small number of condensed rings. The only research
on its biological activity was performed by Taticchi group
(Marrocchi et al. 1996, 2001). To our knowledge, synthesis and
mutagenic activity against S. typhimurium of the compounds
with methyl group, double bond and carbonyl function in cyclo-
pentane ring as well as the influence of benzannelations of
rings A and D of this skeleton have been described in only
two publications (Marrocchi et al. 1996, 2001).
Among the compounds mentioned above, unsubstituted
CP[c]P (4) exhibits the strongest mutagenic properties. The in-
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troduction of carbonyl function in position 1 (34) causes the 
fading of mutagenic activity, and this has been explained as the
excessive steric hindrance in pseudo fjord-region. The same
explanation was given in the case of the compound (38),
which has a double bond and methyl substituents at C-1 carbon
atom. These compounds and their mutagenic properties are
shown in Scheme 15.
Scheme 15
Among hydrocarbons consisting of five condensed rings,
only compound 39 exhibits mutagenic properties; however, its
activity is much lower than the activity of CP[c]P (Marrocchi
et al. 1996).
Benzo[c]phenanthrene
B[c]P differs significantly from the carbon skeletons described
above. Unsubstituted B[c]P (3) is such a strong carcinogen that
it serves as a positive control in biological research. In most of
the avaliable papers, the authors consider establishing new
methods for determination of mutagenic or carcinogenic pro-
perties of PAHs with the use of B[c]P (3) (Buterin et al. 2000).
Metabolites of B[c]P (3) are of great importance and interest;
strong carcinogenic (Amin et al. 1995; Hecht et al. 1994; Seidel
et al. 1995) and mutagenic (Glatt et al. 1991; Wood et al. 1984;)
properties of products of their enzymatic oxidation were deter-
mined using different techniques, tests and cell lines or bacterial
strains. In every case, anti-3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetra-
hydroB[c]P exhibited the strongest activity. The metabolic path-
way of B[c]P (3) was investigated in details with the use of gene-
tically modified hamster V79 cells, which had three forms of rat
cytochrome P450 and six forms of human cytochrome (Seidel et
al. 1998). Studies comparing the carcinogenicity of metabolites
of 5,6-dimethylchrysene and B[c]P proved that among diolepo-
xides formed from both compounds the metabolite of B[c]P
exhibited the strongest carcinogenic activity (Amin et al. 1993).
Investigations on the biological activity of 1,4-dimethyl-B[c]P
and the synthesis, metabolism, and structure of its metabolites
were performed by the group of Lakshman (Lakshman et al.
2000). In comparison to an unsubstituted hydrocarbon, the
substitution of a fjord-region with methyl group significantly
decreases carcinogenic activity of metabolites of this compound.
As the metabolic pathway of B[c]P (3) leads mostly through the
stadium of oxidation of K-region double bond of molecule, the
effort to increase the carcinogenic activity of this compound was
undertaken. The idea was to block this path by substituting C-6
carbon atom with fluorine (Jerina et al. 1982) (Scheme 16).
Scheme 16
The data obtained in this experiment showed the four-fold
increase of carcinogenic activity of the compound substituted
in this manner.
SUMMARY
This attempt to synthesize the present state of knowledge on
the correlation between the structure of chosen PAHs and their
mutagenic or carcinogenic activity shows that the dependencies
cannot be treated univocally. Extreme complexity of the subject,
typical for investigations on the boundary between chemistry
and biology, inclines one to search for new ways of synthesis
of new compounds, which would be of interest for biologists
studying the problem of chemical carcinogenesis. On the other
hand, there is a strong need for elaborating a standardized test
that would explicitly define the carcinogenic properties of 
a specific compound. The use of a variety of methods for the
determination of carcinogenic potency of chemical compounds
combined with simultaneous differentiation of structure of
examined compounds, sometimes leads to contradictory conclu-
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sions. Correlation between mutagenic and carcinogenic activity
of some compounds is also sometimes questionable. Modern
molecular biology should allow for elaborating a method which
would give a satisfactory and reliable answer to the fundamental
question: is a specific compound carcinogenous for a human
organism? And if so – to what extent?
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